Search results for CSL
CSL community
One keyword maps to one global community path.
People
Not Found
Tweets including CSL
CSL REAFFIRMS ITS FY27 GUIDANCE, SAYING IT EXPECTS PRE-TAX TRANSFORMATION SAVINGS TO RISE TO $400 MLN IN FY27 AND UP TO $550 MLN IN FY28, AND THAT IT WILL PROGRESS AN A$1 BLN BUYBACK IN FY26 AND AN A$1.1 BLN BUYBACK IN FY27
Show more
CSL names interim Chief Executive Officer and Managing Director Gordon Naylor as its next chair, replacing Brian McNamee, who is retiring
CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis
CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis
CSL agreed to pay as much as $1.6 billion to jointly develop and sell an experimental treatment for rare kidney and liver diseases, expanding the Australian biotech company’s push into kidney medicine
Show more
CSL SAYS THAT IN CLINICAL DEVELOPMENT, IT IS WORKING WITH AWS TO REDUCE MANUAL EFFORT IN AREAS INCLUDING PROTOCOL AUTHORING.
CSL SAYS IT IS COLLABORATING WITH AMAZON WEB SERVICES TO ADVANCE BIOPHARMACEUTICAL R&D, APPLYING ARTIFICIAL INTELLIGENCE AND CLOUD TECHNOLOGIES TO SUPPORT ITS RESEARCH AND CLINICAL DEVELOPMENT.
CSL SAYS IT DOES NOT ANTICIPATE ANY MATERIAL IMPACT DURING FISCAL YEAR 2027, ADDING THAT THE AGREEMENTS PROVIDE ADDITIONAL CERTAINTY REGARDING ITS EXPOSURE TO U.S. DRUG PRICING AND CERTAIN SECTION 232 TARIFFS.
Show more
CSL HAS ENTERED AGREEMENTS WITH THE U.S. GOVERNMENT TO LOWER DRUG PRICES AND SUPPORT INVESTMENT IN U.S. MANUFACTURING, REFLECTING ITS $1.5 BLN PLAN TO EXPAND U.S. MANUFACTURING CAPACITY IN ILLINOIS, INCLUDING AN ONSHORING AGREEMENT WITH THE U.S. DEPARTMENT OF COMMERCE EXPECTED TO CREATE AT LEAST 300 NEW PHARMACEUTICAL MANUFACTURING JOBS AND APPROXIMATELY 800 CONSTRUCTION AND RELATED JOBS.
Show more
Australia's CSL names interim CEO Gordon Naylor as new chair
